Statistics for Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial
Total visits
views | |
---|---|
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial | 188 |
Total visits per month
views | |
---|---|
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
File Visits
views | |
---|---|
Bolli_2018_rationale.pdf | 268 |
java.util.UUID:08b9e1ca-619d-4834-88c4-86e70f1d69a0 | 7 |
java.util.UUID:396a6394-2391-4f41-a23f-5a602a16a214 | 5 |
java.util.UUID:5b3b0e87-9ce0-4236-a614-123f039f96f7 | 3 |
Top country views
views | |
---|---|
United States | 132 |
Germany | 8 |
China | 7 |
Russia | 7 |
Ukraine | 5 |
United Kingdom | 3 |
Belgium | 2 |
Canada | 2 |
Italy | 1 |
Malaysia | 1 |
Netherlands | 1 |
Top city views
views | |
---|---|
Wilmington | 47 |
Fairfield | 25 |
Houston | 9 |
Jacksonville | 7 |
Kiez | 7 |
Cambridge | 6 |
Kiev | 5 |
Ling | 5 |
Ann Arbor | 4 |
Saint Petersburg | 3 |
Beijing | 2 |
Dearborn | 2 |
Ryazan | 2 |
San Francisco | 2 |
Schoten | 2 |
Washington | 2 |
Abingdon | 1 |
Bristol | 1 |
Brooklyn | 1 |
Commack | 1 |
Den Haag | 1 |
Gunzenhausen | 1 |
Milan | 1 |
Mountain View | 1 |
Ottawa | 1 |
Philadelphia | 1 |
Scottsdale | 1 |
Seremban | 1 |
Toronto | 1 |